Albemarle Corp Valuation – March 2018 $ALB
Albemarle Corporation does not satisfy the requirements of either the Enterprising Investor or the more conservative Defensive Investor. The Defensive Investor is concerned with the insufficient earnings growth over the last ten years, and the high PEmg and PB ratios.
Albany International Corp Valuation – Initial Coverage $AIN
Albany International Corp. is suitable for the Enterprising Investor but not the more conservative Defensive Investor. The Defensive Investor is concerned with the small size, insufficient earnings stability or growth over the last ten years, and the high PEmg and PB ratios.
Albemarle Corporation Valuation – August 2016 $ALB
Albemarle Corporation does not satisfy the requirements of either the Enterprising Investor or the more conservative Defensive Investor. The Defensive Investor is concerned with the low current ratio, insufficient earnings growth over the last ten years, and the high PEmg and PB ratios.
Albemarle Corporation Valuation – November 2015 Update $ALB
Albemarle Corporation qualifies for either the Enterprising Investor or the more conservative Defensive Investor. The Defensive Investor is only initially concerned by the low current ratio, while the Enterprising Investor is satisfied because the company meets the more stringent Defensive Investor requirements.
Albemarle Corporation Analysis – Initial Coverage $ALB
Albemarle Corporation is suitable for the more conservative Defensive Investor and the Enterprising Investor. The Defensive Investor is only concerned with the low current ratio. The Enterprising Investor has concerns but is willing to overlook them since the company passes the more stringent Defensive Investor requirements.
Pfizer Inc ($PFE) – Valuation May 2023
Company Profile (excerpt from Wikipedia): Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer (1824–1906) and his cousin Charles F. Erhart (1821–1891). Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company’s largest products by sales are the Pfizer–BioNTech COVID-19 vaccine ($37 billion in 2022 revenues), Nirmatrelvir/ritonavir ($18 billion in 2022 revenues), Apixaban ($6 […]